Chemoinformaics analysis of Ixocarpalactone A
| Molecular Weight | 504.62 | nRot | 3 |
| Heavy Atom Molecular Weight | 464.3 | nRig | 30 |
| Exact Molecular Weight | 504.272 | nRing | 6 |
| Solubility: LogS | -4.162 | nHRing | 2 |
| Solubility: LogP | 2.091 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 76 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 8 | APOL | 79.8477 |
| nHD | 4 | BPOL | 45.3363 |
| QED | 0.391 |
| Synth | 6.181 |
| Natural Product Likeliness | 3.029 |
| NR-PPAR-gamma | 0.015 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.992 |
| Pgp-sub | 0.358 |
| HIA | 0.498 |
| CACO-2 | -5.087 |
| MDCK | 0.0000693 |
| BBB | 0.956 |
| PPB | 0.494087 |
| VDSS | 0.724 |
| FU | 0.418587 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.623 |
| CYP2c19-inh | 0.006 |
| CYP2c19-sub | 0.909 |
| CYP2c9-inh | 0.011 |
| CYP2c9-sub | 0.114 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.198 |
| CYP3a4-inh | 0.238 |
| CYP3a4-sub | 0.843 |
| CL | 18.351 |
| T12 | 0.225 |
| hERG | 0.012 |
| Ames | 0.048 |
| ROA | 0.951 |
| SkinSen | 0.019 |
| Carcinogencity | 0.067 |
| EI | 0.006 |
| Respiratory | 0.735 |
| NR-Aromatase | 0.341 |
| Antiviral | Yes |
| Prediction | 0.738343 |